tradingkey.logo
tradingkey.logo
Buscar

Microbot Medical Inc

MBOT
Añadir a la lista de seguimiento
1.910USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
128.28MCap. mercado
PérdidaP/E TTM

Más Datos de Microbot Medical Inc Compañía

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Información de Microbot Medical Inc

Símbolo de cotizaciónMBOT
Nombre de la empresaMicrobot Medical Inc
Fecha de salida a bolsaMar 25, 1992
Director ejecutivoGadot (Harel)
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 25
Dirección175 Derby St Bld 27
CiudadHINGHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02043
Teléfono17818753605
Sitio Webhttp://www.microbotmedical.com/
Símbolo de cotizaciónMBOT
Fecha de salida a bolsaMar 25, 1992
Director ejecutivoGadot (Harel)

Ejecutivos de Microbot Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Microbot Medical Inc?

Los cinco principales accionistas de Microbot Medical Inc son: Mr. Harel Gadot

¿Cuántas instituciones poseen acciones de Microbot Medical Inc (MBOT)?

A fecha de 2026Q1, 131 instituciones poseen acciones de Microbot Medical Inc, con un valor de mercado combinado de aproximadamente 15.51M, lo que representa el 23.09% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 5340824.00.